Confluent

Confluent's Valuation: Is the Recent Share Price Justified?

First Foundation

Clearwater Analytics

Investor Rights Law Firm Investigating Clearwater, First Foundation, and Confluent Sales

Citizens Downgrades Confluent to Market Perform from Market Outperform.

Confluent shareholders may be shortchanged in proposed IBM acquisition.

Confluent CFLT CRO Mac Ryan Norris sells shares at $29.96.

Catalyst<ul> <li>Strong cash reserves relative to market value provide a buffer and indicate financial stability for CFLT.</li></ul>Risk<ul> <li>Technical indicators show the market is in a weak state, with bearish signals dominating and a risk of decline for CFLT.</li> <li>Fund flows are trending negative across all order sizes, indicating a lack of institutional or retail confidence in CFLT.</li> <li>Analyst ratings are currently neutral, but with differences in consensus, suggesting uncertainty or lack of strong institutional optimism for CFLT.</li></ul>

Key Factors

Confluent's share price is currently valued at $30.57, which is 19.5% above the intrinsic value of $25.58 estimated by a Discounted Cash Flow model.

Recent Updates

CFLT News